Cell cycle in vasculoproliferative diseases: potential interventions and routes of delivery.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Circulation

• Publication date

  2001-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.103.19.2414PMID 11352893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study

  2001cited by this paper
• Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans.

  2000cited by this paper
• Intrapericardial Paclitaxel Delivery Inhibits Neointimal Proliferation and Promotes Arterial Enlargement After Porcine Coronary Overstretch

  2000cited by this paper
• Inhibition of Vascular Smooth Muscle Cell Proliferation by Sodium Salicylate Mediated by Upregulation of p21Waf1 and p27Kip1

  2000cited by this paper
• Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months.

  2000cited by this paper
• Biodegradable stents : "fulfilling the mission and stepping away".

  2000cited by this paper
• Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo.

  2000cited by this paper
• Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries

  2000cited by this paper
• Inhibition of Vascular Smooth Muscle Cell Proliferation by Sodium Salicylate Mediated by Upregulation of p21 and p27

  2000cited by this paper
• Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.

  2000cited by this paper
• Efficient in vivo catheter‐based pericardial gene transfer mediated by adenoviral vectors

  1999cited by this paper
• Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.

  1999cited by this paper
• A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.

  1999cited by this paper
• Chimeric DNA-RNA hammerhead ribozyme to proliferating cell nuclear antigen reduces stent-induced stenosis in a porcine coronary model.

  1999cited by this paper
• Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.

  1999cited by this paper
• Adenovirus-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle proliferation and induces apoptosis

  1999cited by this paper
• Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat.

  1999cited by this paper
• Percutaneous Adenoviral Gene Transfer into Porcine Coronary Arteries: Is Catheter-Based Gene Delivery Adapted to Coronary Circulation?

  1999cited by this paper
• How the cyclin became a cyclin: Regulated proteolysis in the cell cycle

  1999cited by this paper
• Adenovirus-Mediated Expression of a Ribozyme to c-mybmRNA Inhibits Smooth Muscle Cell Proliferation and Neointima Formation In Vivo

  1999cited by this paper
• Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

  1999cited by this paper
• ATP-site directed inhibitors of cyclin-dependent kinases.

  1999cited by this paper
• How the cyclin became a cyclin: regulated proteolysis in the cell cycle.

  1999cited by this paper
• Gene therapy for restenosis: are we ready?

  1998cited by this paper
• GATA-6 Induces p21Cip1 Expression and G1Cell Cycle Arrest*

  1998cited by this paper
• Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo.

  1998cited by this paper
• Nitric oxide-induced downregulation of Cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells.

  1998cited by this paper
• Bioresorbable Microporous Stents Deliver Recombinant Adenovirus Gene Transfer Vectors to the Arterial Wall

  1998cited by this paper
• Nitric Oxide – Induced Downregulation of Cdk 2 Activity and Cyclin A Gene Transcription in Vascular Smooth Muscle Cells

  1998cited by this paper
• Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo.

  1998cited by this paper
• Expression of cyclin-dependent kinase inhibitors in vascular disease.

  1998cited by this paper
• Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty.

  1997cited by this paper
• CVT-313, a Specific and Potent Inhibitor of CDK2 That Prevents Neointimal Proliferation*

  1997cited by this paper
• Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty.

  1997cited by this paper
• p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene.

  1997cited by this paper
• Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation.

  1997cited by this paper
• Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.

  1997cited by this paper
• Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury.

  1996cited by this paper
• The Intima: Soil for Atherosclerosis and Restenosis

  1995cited by this paper
• A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

  1995cited by this paper
• Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery.

  1994cited by this paper
• Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.

  1994cited by this paper
• Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

  1993cited by this paper
• Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium.

  1983cited by this paper

• Single Intraluminal Delivery of a Nitric Oxide-Donor Results in Inhibition of Intimal Thickening in the Rabbit Femoral Artery

  2025cites this paper
• Mitogen signaling strength and duration can control cell cycle decisions

  2024cites this paper
• Review: Cancer and neurodevelopmental disorders: multi-scale reasoning and computational guide

  2024cites this paper
• Ginsenoside Rb1 protects human vascular smooth muscle cells against resistin-induced oxidative stress and dysfunction

  2023cites this paper
• Huotan Jiedu Tongluo Decoction Inhibits Balloon-Injury-Induced Carotid Artery Intimal Hyperplasia in the Rat through the PERK-eIF2α-ATF4 Pathway and Autophagy Mediation

  2021influential citation
• Identification of potential crucial genes and pathways associated with vein graft restenosis based on gene expression analysis in experimental rabbits

  2018cites this paper
• Non-polymer drug-eluting coronary stents

  2018cites this paper
• Testosterone replacement attenuates intimal hyperplasia development in an androgen deficient model of vascular injury.

  2017cites this paper
• Atherosclerosis and Cancer; A Resemblance with Far-reaching Implications.

  2017cites this paper
• Trichosanthin attenuates vascular injury-induced neointimal hyperplasia following balloon catheter injury in rats

  2017cites this paper
• 3-[(Dodecylthiocarbonyl)Methyl]-Glutarimide Attenuates Graft Arterial Disease by Suppressing Alloimmune Responses and Vascular Smooth Muscle Cell Proliferation

  2015cites this paper
• Salvianolic acid B inhibits atherogenesis of vascular cells through induction of Nrf2-dependent heme oxygenase-1.

  2014cites this paper
• Silencing heat shock protein 27 (HSP27) inhibits the proliferation and migration of vascular smooth muscle cells in vitro

  2014cites this paper
• Indole-3-carbinol blocks platelet-derived growth factor-stimulated vascular smooth muscle cell function and reduces neointima formation in vivo.

  2013cites this paper
• Inhibitory Effects and Mechanisms of Luteolin on Proliferation and Migration of Vascular Smooth Muscle Cells

  2013cites this paper
• Nanotechnology-based gene-eluting stents.

  2013cites this paper
• MicroRNAs: Novel diagnostic and prognostic biomarkers in atherosclerosis.

  2013cites this paper
• MicroRNA-33 in atherosclerosis etiology and pathophysiology.

  2013cites this paper
• Apigenin attenuates neointima formation via suppression of vascular smooth muscle cell phenotypic transformation

  2012cites this paper
• Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis

  2012cites this paper
• Inhibitory Effect of Ginsenoside Rg1 on Vascular Smooth Muscle Cell Proliferation Induced by PDGF-BB Is Involved in Nitric Oxide Formation

  2012cites this paper
• Limus is not limus--a proposal to adjust terminology in the context of drug-eluting stents.

  2012cites this paper
• Canonical Transient Receptor Potential Channel Expression, Regulation, and Function in Vascular and Airway Diseases

  2012cites this paper
• Cell cycle regulation by carboxylated multiwalled carbon nanotubes through p53-independent induction of p21 under the control of the BMP signaling pathway.

  2012cites this paper
• Ginsenoside Rb₁ inhibits the carotid neointimal hyperplasia induced by balloon injury in rats via suppressing the phenotype modulation of vascular smooth muscle cells.

  2012cites this paper
• Drug eluting stents: current status and new developments.

  2012cites this paper
• (2S)-naringenin from Typha angustata inhibits vascular smooth muscle cell proliferation via a G0/G1 arrest.

  2012cites this paper
• Comparison of restenosis rate with sirolimus-eluting stent i n STEMI patients with and without diabetes at 6-month angiographic follow-up

  2011cites this paper
• Total Ginsenosides suppress the neointimal hyperplasia of rat carotid artery induced by balloon injury.

  2011cites this paper
• Caffeic Acid Phenethyl Ester Inhibits Proliferation and Migration, and Induces Apoptosis in Platelet-Derived Growth Factor-BB-Stimulated Human Coronary Smooth Muscle Cells

  2011cites this paper
• Anti-Proliferative Activity of OD78 Is Mediated through Cell Cycle Progression by Upregulation p27 in Rat Aortic Vascular Smooth Muscle Cells

  2011cites this paper
• Modulation of cell adhesion, proliferation and differentiation on materials designed for body implants.

  2011cites this paper
• Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression

  2011cites this paper
• Anti-Proliferative Activity of OD78 Is Mediated through Cell Cycle Progression by Upregulation p27 kip1 in Rat Aortic Vascular Smooth Muscle Cells

  2011cites this paper
• Ginsenoside Rg1 inhibits vascular intimal hyperplasia in balloon-injured rat carotid artery by down-regulation of extracellular signal-regulated kinase 2.

  2011cites this paper
• Critical Stages in the Development of the First Targeted, Injectable Molecular-Genetic Medicine for Cancer

  2011cites this paper
• Atherosclerosis and cell cycle: put the brakes on! Critical role for cyclin-dependent kinase inhibitors.

  2010cites this paper
• The proliferation and differentiation of placental-derived multipotent cells into smooth muscle cells on fibrillar collagen.

  2010cites this paper
• Targeted endothelial nitric oxide synthase gene delivery with lipopolyplexes for the treatment of coronary restenosis

  2009cites this paper
• Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery.

  2009cites this paper
• Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine.

  2009cites this paper
• Modulating the Functional Contributions of c-Myc to the Human Endothelial Cell Cyclic Strain Response

  2009cites this paper
• Caldesmon as a therapeutic target for proliferative vascular diseases.

  2008cites this paper
• Perivascular Delivery of Rapamycin in Pluronic Gel Inhibits Neointimal Hyperplasia in a Rat Carotid Artery Injury Model, and the Complementary Role of Carotid Arteriography

  2008cites this paper
• BEYOND ONCOGENESIS: THE ROLE OF S-PHASE KINASE-ASSOCIATED PROTEIN-2 (SKP2) IN VASCULAR RESTENOSIS

  2008cites this paper
• Inhibition of Apoptosis Through Localized Delivery of Rapamycin-Loaded Nanoparticles Prevented Neointimal Hyperplasia and Reendothelialized Injured Artery

  2008cites this paper
• YSK2821, a newly synthesized indoledione derivative, inhibits cell proliferation and cell cycle progression via the cell cycle-related proteins by regulating phosphatidylinositol-3 kinase cascade in vascular smooth muscle cells.

  2008cites this paper
• PKCdelta mediates anti-proliferative, pro-apoptic effects of testosterone on coronary smooth muscle.

  2007cites this paper
• Local Gene and Cell Delivery Devices

  2007cites this paper
• Epothilone B Inhibits Neointimal Formation after Rat Carotid Injury through the Regulation of Cell Cycle-Related Proteins

  2007cites this paper
• Nanoparticulate carriers for the treatment of coronary restenosis

  2007cites this paper
• Epothilone D, a microtubule-stabilizing compound, inhibits neointimal hyperplasia after rat carotid artery injury by cell cycle arrest via regulation of G1-checkpoint proteins.

  2007cites this paper
• Bilirubin and Biliverdin Treatment of Atherosclerotic Diseases

  2007cites this paper
• Expression and function of periostin-like factor in vascular smooth muscle cells.

  2007cites this paper
• Ginsenoside Rg1 inhibits tumor necrosis factor-alpha (TNF-alpha)-induced human arterial smooth muscle cells (HASMCs) proliferation.

  2006cites this paper
• Ginsenoside Rg1 inhibits tumor necrosis factor‐α (TNF‐α)‐induced human arterial smooth muscle cells (HASMCs) proliferation

  2006cites this paper
• Inhibition of Smooth Muscle Proliferation by Urea-Based Alkanoic Acids via Peroxisome Proliferator-Activated Receptor &agr;–Dependent Repression of Cyclin D1

  2006cites this paper
• Resting smooth muscle cells as a model for studying vascular cell activation.

  2006cites this paper
• The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

  2006cites this paper
• Dependent Repression of Cyclin D 1 − α Proliferator-Activated Receptor Inhibition of Smooth Muscle Proliferation by Urea-Based Alkanoic Acids via Peroxisome

  2006cites this paper
• Intrapericardial drug delivery for prevention of restenosis Dongming Hou and Keith L March

  2005cites this paper
• Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries.

  2005cites this paper
• Characterization of Mesenchyme Homeobox 2 (MEOX2) transcription factor binding to RING finger protein 10

  2005cites this paper
• Bilirubin: A Natural Inhibitor of Vascular Smooth Muscle Cell Proliferation

  2005cites this paper
• Intimal Hyperplasia and Luminal Stenosis of Arteriovenous Polytetrafluoroethylene-Adrenergic Receptor Kinase C-Terminus Reduces β Adenovirus-Mediated Expression of Print

  2005cites this paper
• Identification of active siRNAs against IGF-IR of porcine coronary smooth muscle cells in a heterologous cell line.

  2005cites this paper
• Interference by interferons: Janus faces in vascular proliferative diseases.

  2005cites this paper
• Calcium and the replication of human vascular smooth muscle cells: studies on the activation and translocation of extracellular signal regulated kinase (ERK) and cyclin D1 expression.

  2005cites this paper
• Compartmentalization of hnRNP‐K during cell cycle progression and its interaction with calponin in the cytoplasm

  2005cites this paper
• Adenovirus-Mediated Expression of &bgr;-Adrenergic Receptor Kinase C-Terminus Reduces Intimal Hyperplasia and Luminal Stenosis of Arteriovenous Polytetrafluoroethylene Grafts in Pigs

  2005cites this paper
• Update on sirolimus drug-eluting stents.

  2004cites this paper
• Fas ligand gene therapy for vascular intimal hyperplasia.

  2004cites this paper
• Intramuscular gene transfer of CGRP inhibits neointimal hyperplasia after balloon injury in the rat abdominal aorta.

  2004cites this paper
• Catheter‐mediated delivery of adenoviral vectors expressing β‐adrenergic receptor kinase C‐terminus inhibits intimal hyperplasia and luminal stenosis in rabbit iliac arteries

  2004cites this paper
• A comprehensive approach to visual and functional assessment of experimental vascular lesions in vivo.

  2004cites this paper
• Local cyclin‐dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug‐ eluting stents to prevent neointima formation following vascular injury

  2004cites this paper
• Local Endovascular Delivery, Gene Therapy, and Cell Transplantation for Peripheral Arterial Disease

  2004cites this paper
• Trypanosoma cruzi Infection Activates Extracellular Signal-Regulated Kinase in Cultured Endothelial and Smooth Muscle Cells

  2004cites this paper
• Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary Stent: The European evaLUation of pacliTaxel Eluting Stent (ELUTES) Trial

  2004cites this paper
• Futuro del tratamiento farmacológico de las enfermedades cardiovasculares

  2004cites this paper
• Green tea polyphenol epigallocatechin‐3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53

  2003cites this paper
• Break the Cycle: The Role of Cell-Cycle Modulation in the Prevention of Vasculoproliferative Diseases

  2003cites this paper
• Non‐steroidal anti‐inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycle

  2003cites this paper
• Molecular biology in diagnostic histopathology: Part 1 – The cell cycle

  2003cites this paper
• Sirolimus eluting stent: a new era in interventional cardiology?

  2003cites this paper
• Akt Controls Vascular Smooth Muscle Cell Proliferation In Vitro and In Vivo by Delaying G1/S Exit

  2003cites this paper
• [Recent trend in interventional cardiology--drug-containing stents].

  2003cites this paper
• The role of inflammation in vascular injury and repair

  2003cites this paper
• Activation of Transcription Factors AP-1 and NF-κB in Murine Chagasic Myocarditis

  2003cites this paper
• A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia.

  2003cites this paper
• Genetic Instability, DNA Damage and Atherosclerosis

  2003cites this paper
• Cyclin-dependent kinase inhibitors: cancer killers to neuronal guardians.

  2003cites this paper
• Endoluminal Transplantation of Endothelial Cells

  2003cites this paper
• Peroxisome Proliferator-activated Receptor δ Is Up-regulated during Vascular Lesion Formation and Promotes Post-confluent Cell Proliferation in Vascular Smooth Muscle Cells*

  2002cites this paper
• Drug-eluting stents: from bench to bed.

  2002cites this paper
• Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells.

  2002cites this paper
• RGC-32 Increases p34CDC2 Kinase Activity and Entry of Aortic Smooth Muscle Cells into S-phase*

  2002cites this paper
• New tools for prevention of restenosis could decrease the "oculo-stento" reflex.

  2002cites this paper
• Perspectives of Drug-Eluting Stents

  2002influential citation
• Contemporary revascularization strategies in 2002.

  2002cites this paper